Impact of Acarbose on Abnormal Glucose Regulation in Patients With Coronary Artery Disease (AAA Trial)
Status:
Unknown status
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The objective of this trial is to investigate the effect of early treatment of glucose
toxicity with acarbose, a drug to control postprandial hyperglycemia, on the occurence of
cardiovascular events and the inhibition of atherosclerosis.